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Abstract 
 
The coordination features and signaling of the L-lactate ion by a [Tb(bpcd)]+ (bpcd = N,N′-bis(2-
pyridylmethyl)-trans-1,2-diaminocyclohexane-N,N’-diacetate) complex have been investigated by 
means of a combination of techniques including total luminescence, calorimetry and circularly 
polarized luminescence. The L-lactate/[Tb(bpcd)]+ association constant, determined both by 
luminescence titration and isothermal titration calorimetry, indicates a weak interaction (logK = 1.3 - 
1.45) between the analyte and both enantiomers of the complex. Theoretical DFT calculations suggest 
that the most likely coordination of L-lactate to the possible stereoisomers of the [Tb(S,S-bpcd)]+ 
complex (trans-O,O or trans-Npy,Npy) is that involving the hydroxyl group.  
The results on [Tb(rac-bpcd)]+ as chiroptical luminescent probe of L-lactate underline the peculiar 
role of the chiral 1,2-diaminocyclohexane (DACH) backbone. Indeed, the target anion is capable to 
induce CPL activity from the racemic mixture of Tb complexes containing DACH-based ligand. The 
same is not observed for the achiral analogue [Tb(bped)]+ (bped = N,N’-Bis(2-
Pyridylmethyl)ethylenediamine-N,N’-diacetate) complex which does not produce CPL activity, 
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likely because of the flexibility of the ethylenic group which allows an interconversion between 
different isomers which produce a null net CPL activity. Thanks to the differential quantum yield of 
the two diastereomeric species (R,R)-L and (S,S)-L, one can use the racemic complex to reveal L-
lactate by measuring the induced CPL spectrum. Interestingly this has been demonstrated in a 
commercial complex solution for medical use, containing several electrolytes, namely Ringer’s 
lactate.  
 
 
 Introduction 
 
The detection of the lactate and the monitoring of its concentration is an important task, due to the 
crucial role of this molecule in several fields such as clinical diagnostics, sports medicine, food 
industry and biotechnology1. In particular, lactate is strongly connected to several diseases. For 
example, when sepsis is suspected in a patient, it is recommended to measure the lactate concentration 
promptly.2 Also, abnormally elevated lactate concentrations are revealed in subjects affected by 
Parkinson’s disease3 and high level of serum lactate are also connected to a severe liver pathology.4 
Furthermore, lactate is well known as a specific biomarker for specific types of cancers such as 
prostate and breast cancer.5 Finally, the quantity of lactate in food can be used as an indicator of 
freshness, stability and storage quality, as high level of it can be synonymous of microbial 
contamination.6 In this context, detection of the enantiomeric composition of L/D-lactate can reveal 
food adulterations, like the fraudulent addition of the synthetic racemate. Therefore, the constant need 
of low cost, simple, rapid, highly sensitive and reliable methods for lactate quantification is not 
surprising and enantiospecific response is a further desirable feature. 
In this direction, total luminescence (TL) and circularly polarized luminescence (CPL) spectroscopies 
stemming from f-f transitions of trivalent lanthanide complexes (Ln(III) = Sm(III), Eu(III), Gd(III), 
Tb(III), Dy(III), Yb(III)) can be conveniently exploited, due to several advantages. Firstly, the 
interaction between the target anion (lactate) and the positively charged lanthanide cation can be 
signaled by a unique change of the TL features. In addition, CPL spectroscopy has proven to be 
particularly suitable to track interaction between luminescent molecular probes (even non-chiral or 
racemic ones) with chiral species, such as proteins,7,8 DNA,9 aminoacids,10–13 or chiral ions (lactate 
is a chiral anion) or molecules (sialic acid).14 CPL efficiency is measured in terms of the dissymmetry 
factor (or glum), defined as: glum = 2(IL - IR)/(IL + IR) (with IL and IR the left- and right-polarized 
intensity, respectively). Secondly, since a good limit of sensitivity of the analytical method is 
recommended, a sizable value of the overall luminosity or brightness (B) in aqueous media must be 
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reached.  As B = ∙, with ɛ molar absorption coefficient and  the overall luminescence quantum 
yield, the ligand should be capable to strongly absorb the exciting light (high value of ɛ) and 
efficiently transfer the excitation energy to the lanthanide ion (antenna effect). A proper choice of the 
ligand is also required in order to hamper the intrusion of solvent molecules in the metal ion inner 
coordination sphere. This phenomenon would increase the non-radiative quenching of the Ln(III) 
excited state by multiphonon relaxation processes, one of the main drawbacks, negatively affecting 
the intrinsic quantum yield (Ln). In addition, since the excited states of Tb(III) are less sensitive to 
non-radiative vibrational quenching caused by high energy oscillators (primarily O-H), its complexes 
are suited for applications in aqueous media. Last, the large energy shift between absorbed and 
emitted radiations (in the case of ligand sensitization) and the very narrow emission bands allow the 
separation between Ln(III) luminescence and short-lived background fluorescence in complex.15 
Also, the long emission lifetimes of Ln(III) ions (usually in the milliseconds range), can be exploited 
in order to minimize the interference from autofluorescence, via time-gated detection.16 
We recently studied the coordination chemistry of Eu(III) and Tb(III) ions with ligands carrying the 
chiral 1,2-diaminocyclohexane (DACH) backbone, which have been suitably modified to form stable 
complexes in water.17–20  In particular, we obtained the water soluble Tb-complex 
([Tb(bpcd)(H2O)x]
+, chart 1) characterized by strong Tb-based CPL activity upon excitation of the 
ligand.20 The chiral H2bpcd (N,N′-bis(2-pyridylmethyl)-trans-1,2-diaminocyclohexane-N,N′-
diacetic acid) (Chart 1), tightly binds Ln(III) ions, providing a dissymmetric environment, while at 
the same time leaving 2 - 3 sites available for binding to further ancillary ligands. For all these reasons, 
the Tb-complex can be considered a valuable CPL probe for important analytes in aqueous media. In 
the present contribution we have investigated the optical and chiroptical response of the 
aforementioned Tb complex to L-lactate by means of TL and CPL spectroscopy. The same 
experiments have been also carried out on the analogous Tb complex of the achiral ligand H2bped 
(Chart 1) in order to identify the role of the chiral DACH backbone on the optical and chiroptical 
luminescence signaling of L-lactate.  
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Chart 1. Ligands and complex discussed in the present work. The ligand H2bpcd has been prepared 
in its (S,S), (R,R) and racemic forms. The coordinated water molecules in the Tb(III) complex can be 
easily replaced by an analyte. 
 
DFT calculations, which  have been previously applied successfully to get structural and 
thermochemical data for f-block metal complexes,18,21,22 are used in order to evaluate the relative 
stability of the 1:1 Tb(bpcd)/L-lactate adducts, when the ligand stereochemistry is (S,S).  
Further, the binding constants of these adducts have been determined by means of the Benesi-
Hildebrand method applied on the Tb(III) luminescence emission spectra.  
 
Experimental Section 
TbCl3∙6H2O (Aldrich, 98%) was stored under vacuum for several days at 80°C and then transferred 
in glove box.  
Tb(bpcd)Cl was synthetized by following the procedure reported in literature.20 
The luminescence (TL and CPL) experiments of L-lactate (Alfa Aesar 98%) were carried out as 
follows: To a water solution of the Tb(III) complex (6 mM), increasing quantities of a water solution 
of L-lactate (2.3 M) were added. After each addition, the TL (in the 450-720 nm spectral range) and 
CPL (in the 530-570 nm spectral range) emission spectra and the 5D4 excited state kinetics were 
collected. All the TL spectra have been normalized for the concentration of the Tb(III) ion.  
 
Calorimetry 
An independent determination of the formation constants and the related reaction enthalpy for the 
formation of L-lactate ternary complex with [Tb(rac-bpcd)]+ was performed by Isothermal Titration 
Calorimetry (ITC), which is a largely applied method23,24 to measure the heat involved in the species 
interaction. 
The [Tb(rac-bpcd)]+ complex solution was prepared by diluting stock solutions of the Tb chloride 
hexahydrate salt (Sigma-Aldrich) and the H2bpcd ligand in its racemic form. The Tb content in the 
stock solution was determined by titration with EDTA and xylenol orange as indicator. The stock 
solution of l-lactate was prepared by diluting its sodium salt (Aldrich 99%). All solutions were 
prepared in ultrapure water (over 18 MΩ·cm at 298.15K) from a MilliQ system (ELGA Purelab 
UHQ) and the pH was adjusted to 7.0. 
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The ITC experiment was carried out with a TA instruments TAM III thermostat equipped with a 
nanocalorimeter and an automatic titration syringe at 298.15 K. The lactate solution (25 injections of 
10 µL of L-lactate 80 mM) was added under constant stirring (60 rpm) to a 0.7 ml solution of [Tb(rac-
bpcd)]+ (0.63 mM). The experiment was repeated three times to check the reproducibility of the data. 
The delay time between two consecutive injections was set to 12 min, which was long enough to let 
the system reach thermal equilibrium. The reference cell was filled with MilliQ water with the pH 
adjusted to 7.0. According to the value of its stability constant (logβ = 11.35),20 the [Tb(rac-bpcd)]+ 
species initially present in the cell were about 97% of the total species concentrations at pH 7.0. For 
each titration run, the experimental heats (Qex,j, with j = 1,…n) were collected and corrected for the 
dilution heat Qdil, j, measured in a separate experiment. The net reaction heats, Qobs, j = Qex, j − Qdil, j, 
were analysed by the EST and Solverstat tools.25,26  
 
DFT calculations 
 
As the paramagnetic Eu(III) and Tb(III) complexes are rather difficult to model computationally, the 
analogues of the diamagnetic Y(III) ion have been studied. It has been shown that Y(III) complexes 
may serve as suitable models for the Eu(III) and Tb(III) analogues,27 consistently with the fact that 
its ionic radius differs from that of Eu(III) ion by only 0.02 Å.28 The structure of [M(S,S-
bpcd)(H2O)5]
+ (M = Y(III), La(III)) has been previously optimized20 and two  isomers (trans-O,O 
and trans-Npy,Npy , Chart S1)  have been shown to be equally stable in solution. Furthermore, on the 
basis of the luminescence lifetime results and DFT calculations it has been proposed that also a 
hydration/dehydration equilibrium between species with 2 or 3 coordinated water molecules should 
be present.20  Geometry optimizations of both trans-O,O and trans-Npy,Npy  isomers of the [Y(S,S-
bpcd)(S-lactate)] species with the ligand in the (S,S) stereochemistry were carried out at DFT level in 
vacuum using the B3LYP29,30 exchange–correlation functional. The 6-31+G(d)  basis set has been 
employed for the ligand atoms, while Y(III) ions were described by the quasi-relativistic small core 
Stuttgart-Dresden pseudopotential31 and the relative basis set. This level of theory has been previously 
demonstrated to provide correct geometries and thermochemical properties, maintaining the 
calculation feasible also with similar complex systems.18,21,32 All final geometries were checked to be 
minima by vibrational analysis. Solvent effects have been included by means of the PCM model.33 
All calculations were carried out with Gaussian16.34  
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Luminescence and decay kinetics 
Room temperature luminescence was measured with a Fluorolog 3 (Horiba-Jobin Yvon) 
spectrofluorometer, equipped with a Xe lamp, a double excitation monochromator, a single emission 
monochromator (mod. HR320) and a photomultiplier in photon counting mode for the detection of 
the emitted signal. All the spectra were corrected for the spectral response of the setup.  
In decay kinetics measurements, a xenon microsecond flashlamp was used and the signal was 
recorded by means of multichannel scaling method. Experimental decay times were obtained using 
the convolution of the instrumental response function with an exponential function and the least-
square-sum-based fitting program (SpectraSolve software package). 
The binding interactions between L-lactate and [Tb(R,R-bpcd)]+, [Tb(S,S-bpcd)]+ and [Tb(bped)]+  
were studied using the double reciprocal plot following the Benesi-Hildebrand equation: 
 
I0/(I-I0) = I0/(I∞-I0) + I0/{K∙(I∞-I0)∙[L-lactate]} 
 
where I0,I, and I∞ are the the emission intensity of Tb(III) at 546 nm considered in the absence of L-
lactate, at an intermediate L-lactate concentration and at a concentration of complete interaction, 
respectively. K represents the binding constant and [L-lactate] is the L-lactate concentration. 
 
 
Circularly Polarized Luminescence 
CPL spectra were recorded with the home-made spectrofluoropolarimeter described previously.35 
The spectra were recorded in CD3OD or H2O in 2.0 - 3.0 mM (for [Tb(bpcd)Cl]), under 254 nm 
irradiation using a 90° geometry between the excitation and the detection directions. 
Results and discussion 
L-lactate sensing experiments: Total Luminescence 
In figure 1, the evolution of the Total Luminescence emission spectra of the complex [Tb(R,R-
bpcd)(H2O)]
+ upon addition of L-lactate is presented.  
7 
 
 
Figure 1. Evolution of the total luminescence emission spectra upon addition of the L-lactate anion, 
for complex [Tb(R,R-bpcd)(H2O)x]
+ (λexc = 270 nm). 
 
Thanks to the excitation of the ligand around 270 nm followed by ligand to Tb(III) energy transfer, 
the typical visually green emission originating from the transition of the Tb(III) ion is collected 
(figure 1). Upon addition of L-lactate the intensity of all Tb(III) emission bands increases until 
reaching a plateau when the molar ratio between L-lactate and the metal is around 100. The same 
experiments have been carried out on the Tb(III) complexes of (S,S)-H2bpcd and H2bped ligands 
(Chart 1) and the increase of the relative emission intensity at 546 nm (the maximum of the 5D4→7F5 
band) as a function of the L-lactate molar ratio is shown in figure 2(a). In addition, the Tb(III) 5D4 
excited state lifetimes have been also measured after each addition of L-lactate. All the decay curves 
are well fitted to a single exponential function and the values of the observed lifetimes are reported 
as a function of the L-lactate molar ratio (Figure 2(b)). Upon interacting with the chiral anion, the 
two enantiomeric complexes give rise to a diastereomer pair, which we may shortly define (R,R)-L 
and (S,S)-L, and are characterized by potentially different photophysical properties. 
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 (a) 
 
(b) 
 
Figure 2. (a) Relative emission intensity at 546 nm and (b) Observed lifetime as a function of the L-
lactate to metal molar ratio (L-lactate molar ratio) for Tb complexes with (S,S)-bpcd, (R,R)-bpcd and 
bped ligands (I0 = emission intensity at 546 nm of the starting Tb(III) complex).  
 
As far as the curve profile is concerned, for all the investigated complexes a logarithmic-like trend is 
observed both in figures 2a and 2b. As expected, the relative curves of the [Tb(rac-bpcd)]+ (not 
reported) fall in the middle of the curves of the two enantiomers. For this reason, under this aspect 
the racemic complex will not be discussed further. Whilst the evolution of the lifetime values is very 
similar for the two enantiomeric complexes ([Tb(S,S-bpcd)]+ and [Tb(R,R-bpcd)]+), the increase of 
the relative intensity of the 5D4→7F5 emission band (around 546 nm) is more sensitive to the presence 
of L-lactate in the case of the [Tb(S,S-bpcd)]+ complex (Fig.2a). On the other hand, the achiral 
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[Tb(bped)]+ complex is less sensitive towards L-lactate and the observed lifetime during the titration 
experiment is always lower, in comparison with the lifetime values of the enantiomeric pair 
containing the bpcd ligand. The increase of both emission intensity and the observed lifetimes for all 
the complexes under investigation can be tentatively explained by assuming a replacement of the 
inner sphere water molecules by the target anion. This phenomenon should reduce the non-radiative 
quenching of the Tb(III) excited state caused by the presence in the close proximity of the metal ion 
of OH groups with high vibrational energy.36 On the basis of a similar reasoning, the shorter observed 
lifetimes in the case of [Tb(bped)]+ compound, can be ascribed to the presence of a higher number of 
water molecules close to the metal ion. 
In order to ascertain this point, the decay curves of the Tb(III) 5D4 excited state in H2O and D2O for 
[Tb(bped)]+ complex, are shown in figure S1. 
The curves, well fitted to a single exponential, present a decay constant of 0.81(1) ms and 1.55(1) ms 
in water and D2O, respectively. The number of water molecules in the close proximity to the  metal 
ion  (hydration  number) was calculated by the Horrock’s equation.37,38 As this number [2.5(5)] is the 
same as the one calculated previously for [Tb(rac-bpcd)]+ complex (2.6(5)),20 the reason of the 
aforementioned discrepancy should be sought elsewhere and this point will be discussed in detail 
later in this contribution. 
Finally, the binding constants between L-lactate and [Tb(bpcd)]+ and [Tb(bped)]+complexes have 
been calculated by the Benesi–Hildebrand method.39 In Figure 3, the plot of I0/(I0 − I) vs. [L-lactate]−1 
for the [Tb(S,S-bpcd)]+ complex, shows a good linear relationship, characteristic of 1:1 binding. The 
binding constant can be calculated from the ratio of intercept/slope,40 and its value is 22.6(1) M−1. 
The same calculation performed on the [Tb(R,R-bpcd)]+ and [Tb(bped)]+ complexes (Figure S2) 
provide similar binding constants [28.6(1) and 28.2(1) M-1, respectively]. In the light of these results, 
the adduct between L-lactate and the enantiomeric pair of complexes reveals a similar stability, 
slightly higher in the case of the (R, R) isomer.  
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Figure 3. Benesi–Hildebrand plot against [L-lactate]−1 for the [Tb(S,S-bpcd)]+ complex. I0 is the 
emission intensity at 546 nm of the starting complex; I is the emission intensity at 546 nm of the L-
lactate:complex adduct after each addition of the analyte. 
 
The ITC output during the titration of a [Tb(rac-bpcd)]+ solution with the L-lactate solution is 
reported in Figure 4a (the area of the peaks corresponds to Qex,j). In Figure 4b the total heat evolved 
at the jth  injection1 (Qcum,j) is reported along with the values calculated with the logK and H values 
reported in Table 1. Both, enthalpy and entropy for the formation of [Tb(rac-bpcd)L-lactate] are 
positive, which is often found in charge neutralization reactions in aqueous solutions.41,42  The 
obtained formation constant is in good agreement with that obtained by fluorimetric titration and  very 
similar to the third stepwise formation constant of [Tb(L-lactate)3] and [Eu(L-lactate)3] complexes 
(Table 1).43–45   
In a previous work20 we demonstrated that the complex with bpcd is present in two forms 
energetically equivalent (trans-O,O and trans-Npy, Npy). The formation of the ternary complex with 
lactate implies the removal of two water molecules from these species to produce final complexes 
where the lanthanide is completely dehydrated and the lactate act as chelate, as suggested by the 
longer luminescence lifetimes measured when increasing the lactate/Tb molar rations. The lactate 
anion can chelate lanthanides either through the carboxylate group or the hydroxo/carboxylate 
oxygens.46 Furthermore, it has been proposed45 that in [Eu(lactate)]2+ complex the anion is 
coordinated through carboxyl oxygen and with the deprotonated hydroxyl group (hydroxylate). On 
the contrary, hydroxyl group was considered protonated in the [Eu(lactate)2]
+ and [Eu(lactate)3] 
species.45,46 We calculated the minimum energy structures for the two possible chelation modes of 
                                                 
1 𝑄𝑐𝑢𝑚,𝑗 = ∑ 𝑄𝑜𝑏𝑠,𝑗
𝑗
1  
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the stable coordination isomers with the Y(III) ion (Figure 5) considering the ligand in (S,S) 
configuration and the hydroxyl group to be protonated. The Y-O (lactate) bond lengths reported in 
Table 2 show that the carboxylate group interacts more strongly with [Y(S,S-bpcd)]+ unit when the 
coordination occurs both through the carboxylate and hydroxyl groups as it presents a shorter average 
Y-O bond distance with respect to the other coordination mode. The calculated energy difference in 
gas phase and PCM solvent for the a-d isomers (Table S1) also indicates that the carboxyl- hydroxyl 
coordination is more favored. The trans-O,O isomers have been also studied in presence of 4 explicit 
water molecules (Figure 5 e, f). The Y-O bond distance is further reduced in the e isomer, and it 
results that the hydroxyl group is hydrogen bonded to an outer sphere water molecule. On the 
contrary, the Y-O bond is slightly elongated in the f isomer with respect to b structure. The E 
calculated is still favorable to the hydroxo- carboxy- coordination, in agreement with previous results 
found for the [La(lactate)n]
3-n complexes (Table S1).  
 
a) b) 
 
 
Figure 4. a) ITC titration raw output signal (positive sign here corresponds to an exothermic reaction) 
the obtained Qex have been subtracted by the heat obtained by the dilution experiment with a L-lactate 
solution at the same concentration (titration conditions in Methods section); b) experimental (circles) 
and calculated (solid line) cumulative heat (𝑄𝑐𝑢𝑚,𝑗 = ∑ 𝑄𝑜𝑏𝑠,𝑗
𝑗
1 ) vs. total added lactate volume (Vinj). 
The calculated speciation is also shown.  
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Table 1. Equilibrium constant and thermodynamic parameters for the formation of [Tb(rac-bpcd)L-
lactate] complex (T = 298.15K, I=0.1M NaCl), determined through ITC. Stepwise formation 
constants for the reaction [Ln(lactate)2]+lactate ⇆[Ln(lactate]3] with Ln = Eu3+, Tb3+ (T = 298.15K, 
I=0.2M NaClO4,
43 0.1M NaCl).44,45 Charges omitted for clarity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Reaction logK 
ΔG  
(kJ mol-1) 
ΔH 
(kJ mol-1) 
ΔS 
(J K-1 mol-1) 
[Tb(rac-bpcd)] + L-lactate⇆[Tb(rac-bpcd)L-lactate] 
1.30(9) 
1.35/1.45* 
-7.0(1) 
-7.7 /-8.3 
14.44(5) 
- 
72.4(1) 
- 
[Tb(lactate)2] + Lactate ⇆ [Tb(lactate)3] 
1.1843 -6.7 - - 
1.1544 -6.6 - - 
[Eu(lactate)2] + Lactate ⇆ [Eu(lactate)3] 1.345 -7 - - 
*from fluorimetric titration 
13 
 
a) b) 
 
 
c) d) 
 
 
e) f) 
  
 
Figure 5. Minimum energy structures of the [Y(S,S-bpcd)L-lactate] complex. trans-O,O isomer:  a) 
Ohydoxo, O carboxy chelate,  b) lactate Ocarboxy chelate. trans-Npy, Npy isomer: c) lactate Ohydoxo, Ocarboxy 
chelate,  d) lactate Ocarboxy chelate. Structures e) and f) correspond to structures a) and b) optimized 
with 4 additional solvation water molecules.  
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Table 2. Y-O distances (Å) for the structures reported in Figure 5. For the structures b, d and f the 
average Y-O distance is reported.   
Structure Ln-Ocarboxy Ln-Ohydroxo 
a 2.274 2.505 
b 2.450 - 
c 2.219 2.452 
d 2.352 - 
e 2.250 2.428 
f 2.482 - 
 
 
 
L-lactate sensing: Circularly Polarized Luminescence 
As previously observed, the Tb(III) complex with the chiral ligand bpcd shows a strong CPL activity 
(value for glum around 0.07 at the peak of the 546 nm band).
20 The change of the CPL signal during 
the titration with L-lactate is shown in Figure 6, for both enantiomers and for the racemic complexes. 
 
(a) 
 
15 
 
(b) 
 
(c) 
 
 
Figure 6. Normalized CPL spectra of [Tb(bpcd)]+ complex upon addition of L-lactate for (a) the 
ligand with (R,R) stereochemistry, (b) the ligand with (S,S) stereochemistry and (c) the racemic 
ligand. All the CPL spectra relative to the enantiopure complexes are normalized to the first titration 
point (namely the 1:0 case). 
 
Figure 6 shows a close-up relative to the 5D4→7F5 multiplet, whose multiplicity becomes partly 
resolved, in contrast to the TL counterpart, thanks to some sign alternation of the dichroic signal.   For 
both enantiomers of the complex, upon addition of the target anion, the dichroic signal decreases: this 
means that the adduct with lactate is at the same time more emissive (see Figure 2) but less CPL-
active. 
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This decrease is more prominent for the complex with (R,R) stereochemistry. In fact, the value of 
CPL at 546 nm, normalized to the total emission, shows a 50 % variation from 0 to 100 equivalents 
of L-lactate added, while in the case of the complex with (S,S) stereochemistry the variation is only 
around 17 %. In addition, the glum factor reaches a constant value upon the addition addition of L-
lactate in 20-50 eq. excess.  
During the titration of the racemic complex [Tb(rac-bpcd)]+, L-lactate interacts with one enantiomer 
as much as it does with the other one, on account of the very similar binding constants found in the 
previous section. This means that free (R,R) and (S,S) yield to the bound diastereomer pair (R,R)-L 
and (S,S)-L to the same extent. i.e. the ratios (R,R):(S,S) and (R,R)-L:(S,S)-L remain both constantly 
close to unity. The CPL signals of the two enantiomers of the free complexes will perfectly balance 
and cancel out. On the contrary, for the diastereomeric adducts, being (S,S)-L more emissive than 
(R,R)-L and at the same time the latter less CPL-active than the former one, the total CPL signals do 
not cancel and we must expect that the signal of (S,S)-L diastereomer dominates, which is exactly 
what we observed (Figure 6c).  
The differences in TL (including lifetimes) and CPL for pair (R,R)-L and (S,S)-L witness the 
significant variations in the first coordination sphere for the two diastereomers, possibly both in terms 
of water coordination and of geometry. 
As previously documented,20 the ligands bped and bpcd show similar protonation constants and, as 
far as the stabilities of the respective Gd(III) and Eu(III) complexes are concerned, similar formation 
constants are measured. From a stereochemical point of view, both bped and rac-bpcd can generate 
a pair of similar enantiomeric complexes:  and  conformations, for the dynamically racemic 
[Ln(bped)]+ and (R,R) + (S,S) configurations, for [Ln(rac-bpcd)]+ (Chart 2). The co-presence of the 
 and  conformations in solution is supported by DFT calculations carried out for [Ln(bped)L-
lactate] complex which predict a similar stability of the L and L adducts and the possibility of 
fast interconversion (Figure S3).   
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Chart 2.  and  enantiomers of bped-based complexes (left) and (R,R) and (S,S) enantiomers of rac-
bpcd-based complexes (right).  
 
All this suggests both a similar coordination chemistry of these ligands and similar optical and 
chiroptical response towards L-lactate. Surprisingly, the titration of [Tb(bped)]+ complex with L-
lactate does not produce any CPL activity (Figure S4), this could be related to the distribution of the 
different isomers in rapid equilibrium, as suggested by the small energy differences in Figure S3. 
In order to deepen the reasons for such different behavior, we decided to investigate in detail the 
coordination geometry of the metal ion bound to bped and bpcd ligands. In this context, Eu(III) is 
considered a valuable structural probe as its f-f luminescence is strongly connected with the site 
symmetry of the metal ion. As the ionic size of Tb(III) and Eu(III) are quite similar, all the structural 
conclusion arising from the Eu(III) luminescence in the bped and bpcd-based complexes can be 
extended to their analogues of Tb(III). In this context, the synthesis of [Eu(rac-bpcd)]+ and 
[Eu(bped)]+ complexes was performed and their luminescence emission spectra were collected in 
aqueous solution (Figure 7).  
 
Figure 7. Luminescence emission spectra of [Eu(rac-bpcd)]+ (red circles) and [Eu(bped)]+ (black 
line) complexes, normalized to the area of the 5D0→7F1 band, both 1mM in water upon excitation at 
270 nm. 
 
As previously reported from the inspection of the [Eu(rac-bpcd)]+ luminescence emission spectrum,20 
a C1 point symmetry of the metal ion is suggested. Since the emission spectrum of [Eu(bped)]
+ is 
similar to the one of [Eu(rac-bpcd)]+, the same point symmetry of the metal ion can be assumed in 
both complexes. Nevertheless, the two luminescence emission spectra show one significant 
difference: the value of the asymmetry ratio47,48: 
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which is related to the degree of asymmetry of the coordination polyhedron around the Eu(III) ion. R 
is 2.72 for [Eu(rac-bpcd)]+ and 3.48 for Eu(bped)]+. 
We strongly believe that the different chiroptical behavior detected during the titration of [Tb(rac-
bpcd)]+ and [Tb(bped)]+ with L-lactate could be related with the different coordination geometry 
connected with the degree of distortion of their metal coordination sphere. The same reasoning can 
be adopted in order to justify the discrepancy of the decay constants (see above) during the same 
titration experiments. 
With a view of possible practical applications, we investigated the behavior of [Tb(rac-bpcd)]+ in a 
complex L-lactate-based matrix. We used a commercial Ringer’s lactate solution (Fresenius Kabi) 
used in common clinical practice to treat metabolic acidosis and to replace electrolytes and fluids 
after blood losses. This solution contains sodium L-lactate (28.3 mM) in water alongside with NaCl 
(6.0 g/L), KCl (0.40 g/L) and CaCl2·2H2O (0.27 g/L). By adding to this solution [Tb(rac-bpcd)]
+ to 
obtain a 5 mM solution (1:5.4/Tb(bpcd):L-lactate). As expected, this solution shows a CPL spectrum 
(Figure 8) in agreement with the titration curves (Figure 6c), both in terms of shape and intensity (glum 
~ 6·10-3), thus suggesting the selectivity of [Tb(rac-bpcd)]+ towards the target anion even in real 
complex matrices. It should be emphasized that in Ringer's solution, L-lactate is the only chiral 
species and for this reason, it is ultimately the only possible responsible for the CPL signal from 
[Tb(rac-bpcd)]+. 
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Figure 8. CPL spectrum of [Tb(rac-bpcd)]+ (5 mM) in a commercial Ringer’s lactate solution. 
 
 
 
Conclusions 
 
By means of a combination of techniques, we demonstrated that lactate reversibly binds [Tb(bpcd)]+ 
complex, displacing the water molecules completing Tb(III) coordination sphere in the pristine 
complex. The [Tb(bpcd)]+ complex is chiral, as it incorporates trans-1,2-diaminocyclohexane, which 
is commercially available and rather inexpensive in both enantiomeric forms. The two enantiomers 
of [Tb(bpcd)]+ bind L-lactate to a very similar extent, but the luminescence lifetimes for the two 
diastereomeric adducts (R,R)-L and (S,S)-L are very different, possibly on account of different 
geometries or different dynamics around the emitting center.  
The formation constant of the ternary [Tb(rac-bpcd)L-lactate] complex has been determined both by 
luminescence titration and isothermal titration calorimetry. The data obtained by the two independent 
techniques are in good agreement and show that the L-lactate interacts weakly with the complex (logK 
= 1.3 - 1.45). The associated enthalpy and entropy terms, both positive, are also compatible with the 
complex formation between charged species in water. Further work is envisaged to assess the affinity 
of the [Tb(bpcd)]+ complex for lactate in conditions close to real biological fluids to evaluate the 
effective detection limit and also the selectivity over other competitive anions (e.g. citrate, phosphate, 
bicarbonate…).    
 Theoretical calculations suggest that the most likely coordination mode is that involving the hydroxyl 
group.  
The use of [Tb(bped)]+ and [Tb(rac-bpcd)]+ complexes as chiroptical luminescent probes of L-lactate 
underlines the peculiar role of the chiral DACH backbone: the target anion is capable to induce CPL 
activity from the racemic mixture of Tb complexes containing DACH-based ligand [Figure 6c, 
[Tb(rac-bpcd)]+] but not from [Tb(bped)]+ complex (Figure S4). This evidence is connected with the 
different CPL activity of the two diastereomeric adducts, being (R,R)-L less CPL-active than (S,S)-
L.   
Our findings would lend themselves to the development of an analytical assay based on Tb 
luminescence in the visible.  Moreover, thanks to the differential quantum yield of the two 
diastereomeric species (R,R)-L and (S,S)-L, one can use the racemic complex to reveal L-lactate by 
measuring the induced CPL spectrum. Interestingly this has been demonstrated in a commercial 
complex solution for medical use, containing several electrolytes, namely Ringer’s lactate. The results 
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reported here are encouraging, although the light-absorption features of the ligand and consequently 
the excitation spectrum of the complex are not ideal for practical uses, because they require hard UV 
excitation. We prospect that by manipulating the pyridine chromophore softer excitation can be 
obtained.  
 
 
 
Supporting information.  
Luminescence decay curves, additional structural and energetic results for [Y(bped)]S-lactate] 
complexes and CPL titration of [Tb(bped)]+ with L-lactate. 
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